Meulendijks, Eva R.
Al-Shama, Rushd F. M.
Kawasaki, Makiri
Fabrizi, Benedetta
Neefs, Jolien
Wesselink, Robin
Ernault, Auriane C.
Piersma, Sander
Pham, Thang V.
Jimenez, Connie R.
Knol, Jaco C.
van Boven, Wim J. P.
Driessen, Antoine H. G.
de Vries, Tim A. C.
van der Leeden, Britt
Niessen, Hans W. M.
de Boer, Onno J.
Krul, Sébastien P. J.
de Groot, Joris R.
Funding for this research was provided by:
atricure
Boston scientific
Bayer
Daiichi-Sankyo
Johnson and Johnson
Medtronic
Bristol-Myers Squibb
Article History
Received: 19 March 2023
Accepted: 26 May 2023
First Online: 6 June 2023
Declarations
:
: Both the MARK AF registry and the PREDICT AF study were approved by the Amsterdam University Medical Center medical ethical committee. All participants provided written informed consent.
: We give consent for publication in the Journal of Translational Medicine.
: We have no competing interests.